![Maintenance Olaparib vs Placebo in Germline BRCA-Mutated Metastatic Pancreatic Cancer - The ASCO Post Maintenance Olaparib vs Placebo in Germline BRCA-Mutated Metastatic Pancreatic Cancer - The ASCO Post](https://ascopost.com/media/14020567/3_kindler.jpeg?anchor=center&mode=crop&width=400&height=300&rnd=133035115490000000)
Maintenance Olaparib vs Placebo in Germline BRCA-Mutated Metastatic Pancreatic Cancer - The ASCO Post
![Maharaja Of Jaipur Finds Whitsun Polo Warm Work The Maharaja of Jaipur played for The East in the international polo trial match against America at the Burlingham Club today ( Whit - Maharaja Of Jaipur Finds Whitsun Polo Warm Work The Maharaja of Jaipur played for The East in the international polo trial match against America at the Burlingham Club today ( Whit -](https://c8.alamy.com/comp/2BW3KNH/maharaja-of-jaipur-finds-whitsun-polo-warm-work-the-maharaja-of-jaipur-played-for-the-east-in-the-international-polo-trial-match-against-america-at-the-burlingham-club-today-whit-monday-photo-shows-the-maharaja-of-jaipur-mops-his-neck-between-chukkas-as-his-attendants-wait-with-his-geer-1-june-1936-2BW3KNH.jpg)
Maharaja Of Jaipur Finds Whitsun Polo Warm Work The Maharaja of Jaipur played for The East in the international polo trial match against America at the Burlingham Club today ( Whit -
![Dr. Antonio Calles 🫁🚭 on Twitter: "LBA4 POLO trial: olaparib maintenance in germline BRCA mutant pancreatic adenocarcinoma. Nice data but... PFS as primary endpoint comparing active drug vs no treatment is not Dr. Antonio Calles 🫁🚭 on Twitter: "LBA4 POLO trial: olaparib maintenance in germline BRCA mutant pancreatic adenocarcinoma. Nice data but... PFS as primary endpoint comparing active drug vs no treatment is not](https://pbs.twimg.com/media/D8FZZTVXYAMy4aQ.jpg:large)
Dr. Antonio Calles 🫁🚭 on Twitter: "LBA4 POLO trial: olaparib maintenance in germline BRCA mutant pancreatic adenocarcinoma. Nice data but... PFS as primary endpoint comparing active drug vs no treatment is not
POLO Trial: Olaparib as a maintenance treatment following first-line chemotherapy in patients with metastatic pancreatic cancer on Vimeo
Dr. Antonio Calles 🫁🚭 on Twitter: "LBA4 POLO trial: olaparib maintenance in germline BRCA mutant pancreatic adenocarcinoma. Nice data but... PFS as primary endpoint comparing active drug vs no treatment is not
![Dr Amol Akhade on Twitter: "19 vs 19.2 . POLO . Metastatic pancrease ca. Once again Placebo arm has longer OS than Olaparib. I really appreciate the positive spin off by medical Dr Amol Akhade on Twitter: "19 vs 19.2 . POLO . Metastatic pancrease ca. Once again Placebo arm has longer OS than Olaparib. I really appreciate the positive spin off by medical](https://pbs.twimg.com/media/FXwR4TWaIAAw3vt.jpg:large)